A Retrospective Observational Study of Extended Adjuvant Neratinib for HER2-Positive Early-Stage Breast Cancer in a European Early Access Program.

Križić M, Silovski T, Hoste G, Dedić Plavetić N, Romano O, González Farre X, Cano Jimenez A, Guerrero Zotano A, Suissa J, Beghdad F, Dialla O, Zivanov M, De Laurentiis M.

Open source

DOI: 10.1007/s40487-025-00392-w
Published: 2025-10-29
Container: Oncol Ther
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40487-025-00392-w,
  title = {A Retrospective Observational Study of Extended Adjuvant Neratinib for HER2-Positive Early-Stage Breast Cancer in a European Early Access Program.},
  author = {Križić M and  Silovski T and  Hoste G and  Dedić Plavetić N and  Romano O and  González Farre X and  Cano Jimenez A and  Guerrero Zotano A and  Suissa J and  Beghdad F and  Dialla O and  Zivanov M and  De Laurentiis M.},
  year = {2025},
  journal = {Oncol Ther},
  doi = {10.1007/s40487-025-00392-w},
  url = {https://doi.org/10.1007/s40487-025-00392-w}
}

RIS

TY  - JOUR
TI  - A Retrospective Observational Study of Extended Adjuvant Neratinib for HER2-Positive Early-Stage Breast Cancer in a European Early Access Program.
AU  - Križić M
AU  -  Silovski T
AU  -  Hoste G
AU  -  Dedić Plavetić N
AU  -  Romano O
AU  -  González Farre X
AU  -  Cano Jimenez A
AU  -  Guerrero Zotano A
AU  -  Suissa J
AU  -  Beghdad F
AU  -  Dialla O
AU  -  Zivanov M
AU  -  De Laurentiis M.
PY  - 2025
JO  - Oncol Ther
DO  - 10.1007/s40487-025-00392-w
UR  - https://doi.org/10.1007/s40487-025-00392-w
ER  -

APA

M, K., T, S., G, H., N, D. P., O, R., X, G. F., A, C. J., A, G. Z., J, S., F, B., O, D., M, Z., & M., D. L. (2025). A Retrospective Observational Study of Extended Adjuvant Neratinib for HER2-Positive Early-Stage Breast Cancer in a European Early Access Program.. Oncol Ther. https://doi.org/10.1007/s40487-025-00392-w

Source records

europe-pmc · retrieved 2026-09-27T02:48:15.117Z
doaj · retrieved 2026-09-27T02:48:15.125Z